Market Closed -
Euronext Bruxelles
09:06:45 29/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
12.4
EUR
|
+2.31%
|
|
+3.68%
|
+16.98%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
350.8
|
457.6
|
593.6
|
974.8
|
868.4
|
693.2
|
693.2
|
-
|
Enterprise Value (EV)
1 |
435.4
|
626.9
|
598.2
|
1,123
|
1,117
|
592.6
|
602.9
|
583.9
|
P/E ratio
|
12.1
x
|
18.5
x
|
9.49
x
|
17.9
x
|
13.6
x
|
177
x
|
33.7
x
|
22.9
x
|
Yield
|
3.76%
|
2.89%
|
2.43%
|
1.66%
|
1.99%
|
2.92%
|
2.53%
|
2.24%
|
Capitalization / Revenue
|
0.31
x
|
0.44
x
|
0.72
x
|
0.94
x
|
1.55
x
|
1.12
x
|
1.16
x
|
1.09
x
|
EV / Revenue
|
0.39
x
|
0.6
x
|
0.72
x
|
1.09
x
|
1.99
x
|
1.12
x
|
1.01
x
|
0.92
x
|
EV / EBITDA
|
4.19
x
|
5.47
x
|
10.2
x
|
10.3
x
|
18
x
|
15.1
x
|
11.5
x
|
8.93
x
|
EV / FCF
|
28.8
x
|
38.5
x
|
-28.3
x
|
11.1
x
|
41.5
x
|
20.9
x
|
32.8
x
|
20
x
|
FCF Yield
|
3.47%
|
2.6%
|
-3.54%
|
9.01%
|
2.41%
|
4.79%
|
3.05%
|
5%
|
Price to Book
|
1.32
x
|
1.67
x
|
1.78
x
|
2.53
x
|
1.98
x
|
1.37
x
|
1.59
x
|
1.53
x
|
Nbr of stocks (in thousands)
|
54,900
|
55,071
|
55,373
|
55,637
|
55,882
|
55,904
|
55,904
|
-
|
Reference price
2 |
6.390
|
8.310
|
10.72
|
17.52
|
15.54
|
12.40
|
12.40
|
12.40
|
Announcement Date
|
28/02/19
|
28/02/20
|
26/02/21
|
25/02/22
|
28/02/23
|
29/02/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,118
|
1,039
|
828.8
|
1,033
|
561.5
|
529.4
|
595
|
636.7
|
EBITDA
1 |
103.8
|
114.7
|
58.84
|
109.2
|
62.2
|
39.15
|
52.32
|
65.38
|
EBIT
1 |
63.3
|
51.2
|
23.5
|
66.1
|
43.11
|
15.9
|
27.77
|
39.72
|
Operating Margin
|
5.66%
|
4.93%
|
2.84%
|
6.4%
|
7.68%
|
3%
|
4.67%
|
6.24%
|
Earnings before Tax (EBT)
1 |
39.1
|
28.92
|
-1.5
|
35.13
|
26.16
|
-1.002
|
28.56
|
43.39
|
Net income
1 |
28.8
|
24.76
|
63.2
|
53.52
|
63.18
|
3.31
|
18.4
|
26.4
|
Net margin
|
2.58%
|
2.38%
|
7.63%
|
5.18%
|
11.25%
|
0.63%
|
3.09%
|
4.15%
|
EPS
2 |
0.5300
|
0.4500
|
1.130
|
0.9800
|
1.140
|
0.0600
|
0.3675
|
0.5425
|
Free Cash Flow
1 |
15.1
|
16.28
|
-21.17
|
101.2
|
26.9
|
28.38
|
18.4
|
29.2
|
FCF margin
|
1.35%
|
1.57%
|
-2.55%
|
9.8%
|
4.79%
|
5.36%
|
3.09%
|
4.59%
|
FCF Conversion (EBITDA)
|
14.55%
|
14.19%
|
-
|
92.66%
|
43.26%
|
72.49%
|
35.17%
|
44.67%
|
FCF Conversion (Net income)
|
52.43%
|
65.74%
|
-
|
189.05%
|
42.58%
|
857.43%
|
100%
|
110.61%
|
Dividend per Share
2 |
0.2400
|
0.2400
|
0.2600
|
0.2900
|
0.3100
|
0.3100
|
0.3133
|
0.2775
|
Announcement Date
|
28/02/19
|
28/02/20
|
26/02/21
|
25/02/22
|
28/02/23
|
29/02/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
84.6
|
169
|
4.58
|
148
|
248
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
145
|
90.3
|
109
|
Leverage (Debt/EBITDA)
|
0.815
x
|
1.476
x
|
0.0778
x
|
1.354
x
|
3.995
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
15.1
|
16.3
|
-21.2
|
101
|
26.9
|
28.4
|
18.4
|
29.2
|
ROE (net income / shareholders' equity)
|
15.5%
|
12.6%
|
20.7%
|
14.8%
|
15.1%
|
0.75%
|
5.1%
|
7.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
4.830
|
4.980
|
6.030
|
6.930
|
7.850
|
7.750
|
7.820
|
8.120
|
Cash Flow per Share
2 |
1.050
|
1.210
|
0.0600
|
2.000
|
0.6500
|
0.8300
|
0.8700
|
1.080
|
Capex
1 |
42.3
|
50.5
|
24.3
|
11.5
|
9.75
|
18.5
|
21
|
22.2
|
Capex / Sales
|
3.78%
|
4.86%
|
2.93%
|
1.12%
|
1.74%
|
3.5%
|
3.52%
|
3.49%
|
Announcement Date
|
28/02/19
|
28/02/20
|
26/02/21
|
25/02/22
|
28/02/23
|
29/02/24
|
-
|
-
|
Last Close Price
12.4
EUR Average target price
12.62
EUR Spread / Average Target +1.81% Consensus |
1st Jan change
|
Capi.
|
---|
| +16.98% | 723M | | +4.70% | 103B | | +2.40% | 65.6B | | +42.86% | 39.06B | | +16.96% | 37.58B | | +6.96% | 33.26B | | +7.89% | 19.22B | | +12.12% | 16.83B | | +12.08% | 15.03B | | +17.69% | 14.96B |
Other Commodity Chemicals
|